Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma

NCT01472757 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

374

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: VR506
DRUG: Placebo

Sponsor

Vectura Limited